Dear Shareholder:

The FPA Crescent Fund – Institutional Class (“Fund” or “Crescent”) declined -1.55% for the quarter but gained 16.06% in the trailing twelve months.

Its twelve-month return was 80.3% of the global market (i.e., MSCI AWCI, the “ACWI”), outperforming its own 63.8% average net risk exposure during the same period.

Performance versus Illustrative Indices (%)1

Despite our overall risk exposure being largely unchanged from year-end 2025, there has been activity underfoot.  During the past quarter our two largest purchases were additions to existing positions – Azelis, a small-cap, European-based specialty chemical distributor, and Becton Dickinson, a US-based medical technology company.  In contrast our two largest sales were Alphabet, and TE Connectivity, positions we have held for well over a decade, and which presently share the benefit of being favored by investors for their exposure to artificial intelligence.   The above noted actions are consistent with our activity over the past twelve to eighteen months, which has seen us harvest gains from long-held positions and recycle the proceeds into what we perceive to be undervalued opportunities, namely, SMID caps, international names, and healthcare.

As it relates to other areas of the market that have recently come under pressure, the team is busy evaluating opportunities in several sectors where, if nothing else, valuations are more reasonable than they were a year ago.  We are cognizant however that simply because the multiple on a company has been cut in half, that doesn’t necessarily make for a compelling purchase.  Nonetheless we are in the business of turning over rocks, and in doing so, our hope is that we can find at least a few former gems whose sparkle will ultimately be restored. We are currently building positions in several such names and look forward to providing more details when we publish our midyear letter.

Respectfully submitted,

FPA Crescent Portfolio Managers

April 27, 2026



Crescent’s top five performers contributed 8.78% to its trailing twelve-month return while its bottom five detracted -2.31%.

Trailing Twelve-Month Top and Bottom Contributors (%) as of March 31, 20262


The following companies impacted portfolio performance but have not been recently discussed.3

Glencore functions as one of the largest mining and trading operations in the world, highly leveraged to materials like copper, zinc, and coal, which spiked amid supply disruptions and strong global demand. Shares of Glencore stock rose after reports of a potential merger with Rio Tinto, which subsequently failed to materialize. The company later announced it would return $2 billion to shareholders through cash distributions, following ongoing share repurchases throughout most of 2025.

Longtime holding Aon is among the world’s leading providers of insurance/reinsurance brokerage and human resources solutions. The company reported slowing organic revenue growth for 2025, which led to a slew of sell-side downgrades that pressured the stock price. Aon currently trades at an undemanding multiple of earnings and maintains a long track record of opportunistic acquisitions that have created value for shareholders over time.


FPA Crescent Fund Portfolio Highlights